Investment
Features
FeesSafety
Academy
More
Pluang+

Compare J B Hunt Transport Services Inc (JBHT) vs Eli Lilly And Co (LLY) Price & Performance

J B Hunt Transport Services IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

J B Hunt Transport Services Inc vs Eli Lilly And Co — how do they compare? J B Hunt Transport Services Inc trades at $275.32 (market cap $24.92B), while Eli Lilly And Co trades at $1,215.09 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 43.3× J B Hunt Transport Services Inc's market cap, and J B Hunt Transport Services Inc pays the higher dividend (0.68%). Which is the better fit depends on your goals.

JBHTLLY
Market Cap
$24.92B$1.08T
Sector
IndustrialsHealth
52-Week High
$298.41$1.24K
52-Week Low
$130.65$639.43
Enterprise Value
$26.06B$1.13T
Dividend Yield
0.68%0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

J B Hunt Transport Services Inc

JBHT stock trades at $266.14, down 0.89% on the day, with a bearish technical signal but strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue trends show stabilization after a decline from 2022 peaks, while profitability metrics like ROE at 18.45% and net margin at 5.31% reflect efficient operations. Recent news highlights the company's 65th anniversary and partnerships to enhance freight technology.

The outlook is positive with a consensus price target of $299.82, implying 12.6% upside, supported by analyst buy ratings (57.78%). Risks include economic sensitivity impacting freight demand and competitive pressures. Earnings execution and intermodal demand recovery are key catalysts for stock appreciation.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.

LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About J B Hunt Transport Services Inc

J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).

Read more on JBHT

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY